Literature DB >> 20300878

Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.

Usha Dutta1, Harsh Udawat, Mohd Talha Noor, Gurbakhshish Singh Sidhu, Rakesh Kochhar, Kim Vaiphei, Kartar Singh.   

Abstract

A 20-year-old male presented with low-grade fever, abdominal pain, anorexia, and weight loss of 4-month duration. On examination, he was emaciated. Barium meal follow-through examination showed extensive nodularity and thickening of duodenal and jejunal folds. Contrast-enhanced computed tomography of the abdomen revealed extensive proximal small-bowel thickening with mesenteric lymphadenopathy. Upper gastrointestinal endoscopy and enteroscopy revealed thickening of folds with multiple small superficial ulceration involving antrum, duodenum, and jejunum. The duodenal and jejunal biopsy was suggestive of immunoproliferative small intestinal disease, stage 0 (Salem) or stage A (Galian). Antral biopsy showed presence of Helicobacter pylori infection. He underwent H. pylori eradication following which he had significant clinical improvement; repeat evaluation at 6 months showed dramatic improvement in his clinical, radiological, and histological parameters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300878     DOI: 10.1007/s12029-010-9138-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  15 in total

Review 1.  Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and "Mediterranean" lymphomas.

Authors:  J C Rambaud; M Halphen; A Galian; A Tsapis
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori.

Authors:  S Alkan; D S Karcher; M A Newman; P Cohen
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

3.  Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice.

Authors:  P A Crabbé; D R Nash; H Bazin; H Eyssen; J F Heremans
Journal:  Lab Invest       Date:  1970-05       Impact factor: 5.662

Review 4.  Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.

Authors:  H Akbulut; I Soykan; F Yakaryilmaz; F Icii; F Aksoy; S Haznedaroglu; S Yildirim
Journal:  Cancer       Date:  1997-07-01       Impact factor: 6.860

5.  Spectrum of alpha chain disease in India.

Authors:  V S Swaroop; S H Advani; S R Damle; K A Dinshaw; G V Talwalkar; S Krishnamurthy; R Gopal; C N Nair; S R Shinde; P B Desai
Journal:  Indian J Cancer       Date:  1983 Nov-Dec       Impact factor: 1.224

6.  Small intestinal lymphomas and alpha-chain disease.

Authors:  J C Rambaud
Journal:  Clin Gastroenterol       Date:  1983-09

7.  Immunoproliferative small intestinal disease: portrait of a potentially preventable cancer from the Third World.

Authors:  A Khojasteh; P Haghighi
Journal:  Am J Med       Date:  1990-10       Impact factor: 4.965

8.  Alpha-chain disease and related small-intestinal lymphoma: a memorandum.

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

Review 9.  Immunoproliferative small intestinal disease: Mediterranean lymphoma and alpha heavy chain disease.

Authors:  I G Martin; M I Aldoori
Journal:  Br J Surg       Date:  1994-01       Impact factor: 6.939

10.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

View more
  1 in total

1.  Immunoproliferative Small Intestinal Disease Associated with Overwhelming Polymicrobial Gastrointestinal Infection with Transformation to Diffuse Large B-cell Lymphoma.

Authors:  Evan C Ewers; Robert L Sheffler; James Wang; Viseth Ngauy
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.